In summary, we demonstrated the partial amelioration of myocardial fibrosis by Sal B in a DCM mouse model by inhibiting collagen formation and deposition through the classical TGF-β/Smad pathway. The gene discussed is TGFB1; the disease is Myocardial fibrosis.